Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - TOTAL EQUITY
Total Equity NBIX - Neurocrine Biosciences, Inc.
2.59 B
LAST VALUE
23.14%
2 YEAR CAGR
32.38%
5 YEAR CAGR
28.64%
10 YEAR CAGR